Pei Pang

Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A universal immunocapture LC-MS/MS method for humanized IgG1-based drugs in cynomolgus monkeys.

A universal immunocapture LC-MS/MS method for humanized IgG1-based drugs in cynomolgus monkeys.

Journal: Journal of pharmaceutical and biomedical analysis

Published: December 09, 2025

Integrated analysis of the oncogenic value of CPNE3 in non-small cell lung cancer.

Integrated analysis of the oncogenic value of CPNE3 in non-small cell lung cancer.

Journal: Discover oncology

Published: June 16, 2025

Use of metagenomic next-generation sequencing for accurate diagnosis of tuberculous pleurisy: a retrospective cohort study.

Use of metagenomic next-generation sequencing for accurate diagnosis of tuberculous pleurisy: a retrospective cohort study.

Journal: Journal of thoracic disease

Published: November 30, 2024

A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma.

A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma.

Journal: Cancer biomarkers : section A of Disease markers

Published: March 22, 2024

Time-series analysis of meteorological factors and emergency department visits due to dog/cat bites in Jinshan area, China.

Time-series analysis of meteorological factors and emergency department visits due to dog/cat bites in Jinshan area, China.

Journal: PeerJ

Published: September 22, 2023

Prognostic Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma.

Prognostic Value and Potential Mechanism of MTFR2 in Lung Adenocarcinoma.

Journal: Frontiers in oncology

Published: December 09, 2021

The CPNE Family and Their Role in Cancers.

The CPNE Family and Their Role in Cancers.

Journal: Frontiers in genetics

Published: March 31, 2021

RPB5-mediating protein promotes the progression of non-small cell lung cancer by regulating the proliferation and invasion.

RPB5-mediating protein promotes the progression of non-small cell lung cancer by regulating the proliferation and invasion.

Journal: Journal of thoracic disease

Published: February 11, 2021

MRPL42 is activated by YY1 to promote lung adenocarcinoma progression.

MRPL42 is activated by YY1 to promote lung adenocarcinoma progression.

Journal: Journal of Cancer

Published: August 22, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026